Business Wire

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
Tennessean

Collamer Sets EVO ICL Apart: Carrot LASIK & Eye Center Highlights the Lens Material That’s Changing Vision Correction

Carrot LASIK & Eye Center is shedding light on one of the most important but often overlooked aspects of refractive surgery—the material used in the implantable lens itself. In its latest article, EVO ...
Medical Dialogues

Vertical ICL Fixation Delivers Safer, More Predictable Vault Outcomes: Study Finds

Japan: A study published in the Journal of Refractive Surgery reports that horizontal fixation of implantable collamer lenses ...

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...
Nasdaq

Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL

LAKE FOREST, Calif., Oct. 10, 2023 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is proud to announce a ...